The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Open accessAbstract
SUMMARY The bioactive sphingolipid metabolites ceramide and sphingosine-1-phosphate (S1P) are a recent addition to the lipids accumulated in obesity and have emerged as important molecular players in metabolic diseases. Here we summarize evidence that dysregulation of sphingolipid metabolism correlates with pathogenesis of metabolic diseases in humans. This review discusses the current understanding of how ceramide regulates signaling and metabolic pathways to exacerbate metabolic diseases and the Janus faces for its further metabolite S1P, the kinases that produce it, and the multifaceted and at times opposing actions of S1P receptors in various tissues. Gaps and limitations in current knowledge are highlighted together with the need to further decipher the full array of their actions in tissue dysfunction underlying metabolic pathologies, pointing out prospects to move this young field of research toward the development of effective therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Self-citationSphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,051
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277
Self-citationHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., et al. (2009) · Science · doi:10.1126/science.1176709 · Cited by 997
Self-citationReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
The outs and the ins of sphingosine-1-phosphate in immunity
Spiegel, S., & Milstien, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2974 · Cited by 810
Self-citationThe ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
Crewe, C., An, Y. A., & Scherer, P. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88883 · Cited by 732
Holland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Turpin, S. M., Nicholls, H. T., Willmes, D. M., Mourier, A., Brodesser, S., Wunderlich, C. M., Mauer, J., Xu, E., Hammerschmidt, P., Brönneke, H. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.002 · Cited by 691
Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
An, D., Oh, S. F., Olszak, T., Neves, J. F., Avci, F. Y., Erturk-Hasdemir, D., Lu, X., Zeissig, S., Blumberg, R. S., & Kasper, D. L. (2014) · Cell · doi:10.1016/j.cell.2013.11.042 · Cited by 643
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms10166 · Cited by 559
Luukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461
Raichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.015 · Cited by 455
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Chaurasia, B., Tippetts, T. S., Mayoral Monibas, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 450
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
Regulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Raichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.007 · Cited by 385
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Powell, D. J., Hajduch, E., Kular, G., & Hundal, H. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7794-7808.2003 · Cited by 370
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels
Johnson, E. L., Heaver, S. L., Waters, J. L., Kim, B. I., Bretin, A., Goodman, A. L., Gewirtz, A. T., Worgall, T. S., & Ley, R. E. (2020) · Nature Communications · doi:10.1038/s41467-020-16274-w · Cited by 352
Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 348
Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort
Havulinna, A. S., Sysi-Aho, M., Hilvo, M., Kauhanen, D., Hurme, R., Ekroos, K., Salomaa, V., & Laaksonen, R. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307497 · Cited by 343
Ceramides in Metabolism: Key Lipotoxic Players
Chaurasia, B., & Summers, S. A. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-093815 · Cited by 343
Gillis, A., Gondin, A. B., Kliewer, A., Sanchez, J., Lim, H. D., Alamein, C., Manandhar, P., Santiago, M., Fritzwanker, S., Schmiedel, F., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz3140 · Cited by 336
Wang, D. D., Toledo, E., Hruby, A., Rosner, B. A., Willett, W. C., Sun, Q., Razquin, C., Zheng, Y., Ruiz-Canela, M., Guasch-Ferré, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024261 · Cited by 327
CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity
Hammerschmidt, P., Ostkotte, D., Nolte, H., Gerl, M. J., Jais, A., Brunner, H. L., Sprenger, H.-G., Awazawa, M., Nicholls, H. T., Turpin-Nolan, S. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.008 · Cited by 318
Galvani, S., Sanson, M., Blaho, V. A., Swendeman, S. L., Obinata, H., Conger, H., Dahlbäck, B., Kono, M., Proia, R. L., Smith, J. D., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2581 · Cited by 314
Metabolic Messengers: ceramides
Summers, S. A., Chaurasia, B., & Holland, W. L. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0134-8 · Cited by 299
Chokshi, A., Drosatos, K., Cheema, F. H., Ji, R., Khawaja, T., Yu, S., Kato, T., Khan, R., Takayama, H., Knöll, R., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060889 · Cited by 296
Yang, G., Badeanlou, L., Bielawski, J., Roberts, A. J., Hannun, Y. A., & Samad, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91014.2008 · Cited by 295
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
Bruschi, F. V., Claudel, T., Tardelli, M., Caligiuri, A., Stulnig, T. M., Marra, F., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.29041 · Cited by 268
Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism
Chaurasia, B., Kaddai, V. A., Lancaster, G. I., Henstridge, D. C., Sriram, S., Galam, D. L. A., Gopalan, V., Prakash, K. N. B., Velan, S. S., Bulchand, S., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.002 · Cited by 247
Wang, Y., Aoki, H., Yang, J., Peng, K., Liu, R., Li, X., Qiang, X., Sun, L., Gurley, E. C., Lai, G., et al. (2017) · Hepatology · doi:10.1002/hep.29076 · Cited by 241
Ceramides bind VDAC2 to trigger mitochondrial apoptosis
Dadsena, S., Bockelmann, S., Mina, J. G. M., Hassan, D. G., Korneev, S., Razzera, G., Jahn, H., Niekamp, P., Müller, D., Schneider, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09654-4 · Cited by 234
Law, B. A., Liao, X., Moore, K. S., Southard, A., Roddy, P., Ji, R., Szulc, Z., Bielawska, A., Schulze, P. C., & Cowart, L. A. (2018) · The FASEB Journal · doi:10.1096/fj.201700300r · Cited by 221
Self-citationPlasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
Wigger, L., Cruciani-Guglielmacci, C., Nicolas, A., Denom, J., Fernandez, N., Fumeron, F., Marques-Vidal, P., Ktorza, A., Kramer, W., Schulte, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.019 · Cited by 218
Structural insights into adiponectin receptors suggest ceramidase activity
Vasiliauskaité-Brooks, I., Sounier, R., Rochaix, P., Bellot, G., Fortier, M., Hoh, F., De Colibus, L., Bechara, C., Saied, E. M., Arenz, C., et al. (2017) · Nature · doi:10.1038/nature21714 · Cited by 212
Nagahashi, M., Takabe, K., Liu, R., Peng, K., Wang, X., Wang, Y., Hait, N. C., Wang, X., Allegood, J. C., Yamada, A., et al. (2015) · Hepatology · doi:10.1002/hep.27592 · Cited by 211
Self-citationCeramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes
Russo, S. B., Baicu, C. F., Van Laer, A., Geng, T., Kasiganesan, H., Zile, M. R., & Cowart, L. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63888 · Cited by 211
Self-citationZigdon, H., Kogot-Levin, A., Park, J.-W., Goldschmidt, R., Kelly, S., Merrill, A. H., Scherz, A., Pewzner-Jung, Y., Saada, A., & Futerman, A. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.402719 · Cited by 206
Uptake and Metabolism of Sphingolipids in Isolated Intestinal Loops of Mice
Schmelz, E.-M., Crall, K. J., Larocque, R., Dillehay, D. L., & Merrill, A. H. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.5.702 · Cited by 199
CerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance
Turpin-Nolan, S. M., Hammerschmidt, P., Chen, W., Jais, A., Timper, K., Awazawa, M., Brodesser, S., & Brüning, J. C. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.031 · Cited by 190
Perreault, L., Newsom, S. A., Strauss, A., Kerege, A., Kahn, D. E., Harrison, K. A., Snell-Bergeon, J. K., Nemkov, T., D’Alessandro, A., Jackman, M. R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96805 · Cited by 184
Could Ceramides Become the New Cholesterol?
Summers, S. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.003 · Cited by 183
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
Lemaitre, R. N., Yu, C., Hoofnagle, A., Hari, N., Jensen, P. N., Fretts, A. M., Umans, J. G., Howard, B. V., Sitlani, C. M., Siscovick, D. S., et al. (2018) · Diabetes · doi:10.2337/db17-1449 · Cited by 179
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
Peterson, L. R., Xanthakis, V., Duncan, M. S., Gross, S., Friedrich, N., Völzke, H., Felix, S. B., Jiang, H., Sidhu, R., Nauck, M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007931 · Cited by 179
Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
Kowalski, G. M., Carey, A. L., Selathurai, A., Kingwell, B. A., & Bruce, C. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072449 · Cited by 175
Genetic architecture of human plasma lipidome and its link to cardiovascular disease
Tabassum, R., Rämö, J. T., Ripatti, P., Koskela, J. T., Kurki, M., Karjalainen, J., Palta, P., Hassan, S., Nunez-Fontarnau, J., Kiiskinen, T. T. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11954-8 · Cited by 175
Holland, W. L., Xia, J. Y., Johnson, J. A., Sun, K., Pearson, M. J., Sharma, A. X., Quittner-Strom, E., Tippetts, T. S., Gordillo, R., & Scherer, P. E. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.01.002 · Cited by 174
Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier
Wilkerson, B. A., Grass, G. D., Wing, S. B., Argraves, W. S., & Argraves, K. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423426 · Cited by 173
Skoura, A., Michaud, J., Im, D.-S., Thangada, S., Xiong, Y., Smith, J. D., & Hla, T. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213496 · Cited by 170
Increased de novo ceramide synthesis and accumulation in failing myocardium
Ji, R., Akashi, H., Drosatos, K., Liao, X., Jiang, H., Kennel, P. J., Brunjes, D. L., Castillero, E., Zhang, X., Deng, L. Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96203 · Cited by 166
Hadas, Y., Vincek, A. S., Youssef, E., Żak, M. M., Chepurko, E., Sultana, N., Sharkar, M. T. K., Guo, N., Komargodski, R., Kurian, A. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041882 · Cited by 165
Increased de novo ceramide synthesis and accumulation in failing myocardium
Ji, R., Akashi, H., Drosatos, K., Liao, X., Jiang, H., Kennel, P. J., Brunjes, D. L., Castillero, E., Zhang, X., Deng, L. Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.82922 · Cited by 164
Ruiz, M., Frej, C., Holmér, A., Guo, L. J., Tran, S., & Dahlbäck, B. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308435 · Cited by 162
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis
Xie, C., Yagai, T., Luo, Y., Liang, X., Chen, T., Wang, Q., Sun, D., Zhao, J., Ramakrishnan, S. K., Sun, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4412 · Cited by 161
Anroedh, S. S., Hilvo, M., Akkerhuis, K. M., Kauhanen, D., Koistinen, K. M., Oemrawsingh, R. M., Serruys, P. W. J. C., van Geuns, R., Boersma, E. H., Laaksonen, R., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p081281 · Cited by 157
Bruce, C. R., Risis, S., Babb, J. R., Yang, C., Kowalski, G. M., Selathurai, A., Lee, R. S., Weir, J. M., Yoshioka, K., Takuwa, Y., et al. (2012) · Diabetes · doi:10.2337/db12-0029 · Cited by 154
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism
Turner, N. A., Lim, X. Y., Toop, H. D., Osborne, B., Brandon, A. E., Taylor, E. N., Fiveash, C. E., Govindaraju, H., Teo, J. D., McEwen, H. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05613-7 · Cited by 152
Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans
Bergman, B. C., Brozinick, J. T., Strauss, A., Bacon, S., Kerege, A., Bui, H. H., Sanders, P., Siddall, P., Wei, T., Thomas, M. K., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3850-y · Cited by 148
Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis
Bikman, B. T., Guan, Y., Shui, G., Siddique, M. M., Holland, W. L., Kim, J. Y., Fabriàs, G., Wenk, M. R., & Summers, S. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359950 · Cited by 143
Ooi, G. J., Meikle, P. J., Huynh, K., Earnest, A., Roberts, S. K., Kemp, W., Parker, B. L., Brown, W., Burton, P., & Watt, M. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.013 · Cited by 137
Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity
Skovbro, M., Baranowski, M., Skov-Jensen, C., Flint, A., Dela, F., Górski, J., & Helge, J. W. (2008) · Diabetologia · doi:10.1007/s00125-008-1014-z · Cited by 133
Lee, S., Hong, I., Kim, B., Shim, S., Lee, J., Lee, H., Choi, C. S., Kim, B., & Park, T. (2015) · Hepatology · doi:10.1002/hep.27804 · Cited by 125
Li, C., Zheng, S., You, H., Liu, X., Lin, M., Yang, L., & Li, L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.028 · Cited by 124
Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance
Wang, J., Badeanlou, L., Bielawski, J., Ciaraldi, T. P., & Samad, F. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2013 · Cited by 119
Lone, M. A., Santos, T. C. B., Alecu, I., Silva, L. C., & Hornemann, T. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.12.013 · Cited by 112
Hu, W. M., Ross, J. S., Geng, T., Brice, S. E., & Cowart, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186916 · Cited by 95
Self-citationGeng, T., Sutter, A. G., Harland, M. D., Law, B. A., Ross, J. S., Lewin, D., Palanisamy, A. P., Russo, S. B., Chavin, K. D., & Cowart, L. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m063511 · Cited by 93
Self-citationRusso, S. B., Tidhar, R., Futerman, A. H., & Cowart, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428185 · Cited by 90
Self-citationFrangioudakis, G., Garrard, J. M., Raddatz, K., Nadler, J. L., Mitchell, T. W., & Schmitz‐Peiffer, C. (2010) · Endocrinology · doi:10.1210/en.2010-0250 · Cited by 90
Hu, W. M., Bielawski, J., Samad, F., Merrill, A. H., & Cowart, L. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800635-jlr200 · Cited by 87
Self-citationQi, Y., Chen, J., Lay, A. J., Don, A. S., Vadas, M. A., & Xia, P. (2013) · The FASEB Journal · doi:10.1096/fj.13-230052 · Cited by 81
M., M., Chen, J. L., Wang, G. G., Wang, H., Lu, Y., Li, J. F., Yi, J., Yuan, Y. J., Zhang, Q. W., Mi, J., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0589-5 · Cited by 77
Type 2 diabetes is associated with loss of HDL endothelium protective functions
Vaisar, T., Couzens, E., Hwang, A., Russell, M., Barlow, C. E., DeFina, L. F., Hoofnagle, A. N., & Kim, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192616 · Cited by 77
Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate
Kurano, M., Tsukamoto, K., Shimizu, T., Kassai, H., Nakao, K., Aiba, A., Hara, M., & Yatomi, Y. (2020) · Diabetes · doi:10.2337/db19-0811 · Cited by 74
Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology
Rohrbach, T. D., Maceyka, M. W., & Spiegel, S. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1337706 · Cited by 72
Self-citationLee, S.-Y., Lee, H., Song, J.-H., Kim, G., Jeon, S., Song, Y.-J., Lee, J., Hur, J. H., Oh, H. H., Park, S., et al. (2017) · Diabetes · doi:10.2337/db16-1232 · Cited by 67
Banini, B. A., Kumar, D. P., Cazanave, S. C., Seneshaw, M., Mirshahi, F., Santhekadur, P. K., Wang, L., Guan, H.-P., Oseini, A. M., Alonso, C., et al. (2020) · Hepatology · doi:10.1002/hep.31609 · Cited by 67
Feuerborn, R., Becker, S., Potì, F., Nagel, P., Brodde, M. F., Schmidt, H., Christoffersen, C., Ceglarek, U., Burkhardt, R., & Nofer, J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.12.009 · Cited by 64
The Apolipoprotein M/S1P Axis Controls Triglyceride Metabolism and Brown Fat Activity
Christoffersen, C., Federspiel, C. K., Borup, A., Christensen, P. M., Madsen, A. N., Heine, M., Nielsen, C. H., Kjær, A., Holst, B., Heeren, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.029 · Cited by 63
Ross, J. S., Hu, W. M., Rosen, B. P., Snider, A. J., Obeid, L. M., & Cowart, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477786 · Cited by 62
Self-citationChen, J., Wang, W., Qi, Y., Kaczorowski, D. C., McCaughan, G. W., Gamble, J. R., Don, A. S., Gao, X., Vadas, M. A., & Xia, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.11.006 · Cited by 61
Nwabuo, C. C., Duncan, M. S., Xanthakis, V., Peterson, L. R., Mitchell, G. F., McManus, D. D., Cheng, S. C., & Vasan, R. S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013050 · Cited by 60
Bruce, C. R., Risis, S., Babb, J. R., Yang, C., Lee, R. S., Henstridge, D. C., & Febbraio, M. A. (2012) · Endocrinology · doi:10.1210/en.2012-1847 · Cited by 58
De Novo Sphingolipid Biosynthesis Is Required for Adipocyte Survival and Metabolic Homeostasis
Alexaki, A., Clarke, B. A., Gavrilova, O., Ma, Y., Zhu, H., Ma, X., Xu, L., Tuymetova, G., Larman, B. C., Allende, M. L., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756460 · Cited by 58
Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages
Vaidya, M., Jentsch, J. A., Peters, S., Keul, P., Weske, S., Gräler, M. H., Mladenov, E., Iliakis, G. E., Heusch, G., & Levkau, B. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m088443 · Cited by 58
Rohrbach, T. D., Asgharpour, A., Maczis, M. A., Montefusco, D. J., Cowart, L. A., Bédossa, P., Sanyal, A. J., & Spiegel, S. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093799 · Cited by 57
Self-citationNervonic acid limits weight gain in a mouse model of diet‐induced obesity
Keppley, L. J. W., Walker, S. J., Gademsey, A. N., Smith, J. P., Keller, S. R., KESTER, M. A., & Fox, T. E. (2020) · The FASEB Journal · doi:10.1096/fj.202000525r · Cited by 57
Dairy consumption, plasma metabolites, and risk of type 2 diabetes
Drouin‐Chartier, J., Hernández‐Alonso, P., Guasch‐Ferré, M., Ruiz‐Canela, M., Li, J., Wittenbecher, C., Razquín, C., Toledo, E., Dennis, C., Corella, D., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab047 · Cited by 55
Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions
Bandet, C. L., Mahfouz, R., Véret, J., Sotiropoulos, A., Poirier, M., Giussani, P., Campaña, M. B., Philippe, E., Błachnio-Zabielska, A. U., Ballaire, R., et al. (2018) · Diabetes · doi:10.2337/db17-0901 · Cited by 54
Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes
Chaurasia, B., Li, Y., Talbot, C. L., Maschek, J. A., Cox, J. E., Schuchman, E. H., Hirabayashi, Y., Holland, W. L., & Summers, S. A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101145 · Cited by 54
Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
Aji, G., Huang, Y., Ng, M. L., Wang, W., Lan, T., Li, M., Li, Y., Chen, Q., Li, R., Yan, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007856117 · Cited by 53
Kitada, Y., Kajita, K., Taguchi, K., Mori, I., Yamauchi, M., Ikeda, T., Kawashima, M., Asano, M., Kajita, T., Ishizuka, T., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1768 · Cited by 52
Denimal, D., Monier, S., Brindisi, M., Petit, J., Bouillet, B., Nguyen, A., Demizieux, L., Simoneau, I., de Barros, J.-P. P., Vergès, B. L., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309287 · Cited by 50
Sphingolipids as Regulators of Autophagy and Endocytic Trafficking
Young, M. M., & Wang, H. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.04.008 · Cited by 46
Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
Kolak, M., Gertow, J., Westerbacka, J., Summers, S. A., Liška, J., Franco‐Cereceda, A., Orešič, M., Yki‐Järvinen, H., Eriksson, P. O., & Fisher, R. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-115 · Cited by 44
Wang, K., Li, C., Lin, X., Sun, H., Xu, R., Li, Q., Wei, Y., Li, Y., Qian, J., Liu, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2214-9 · Cited by 42
Ishimaru, K., Yoshioka, K., Kano, K., Kurano, M., Saigusa, D., Aoki, J., Yatomi, Y., Takuwa, N., Okamoto, Y., Proia, R. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54877-6 · Cited by 40
Sphk2−/− mice are protected from obesity and insulin resistance
Ravichandran, S., Finlin, B. S., Kern, P. A., & Özcan, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.012 · Cited by 39
Poirier, B., Briand, V., Kadereit, D., Schäfer, M., Wohlfart, P., Philippo, M.-C., Caillaud, D., Gouraud, L., Grailhe, P., Bidouard, J., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax8050 · Cited by 39
Involvement of Sphingosine 1-Phosphate in Palmitate-Induced Non-Alcoholic Fatty Liver Disease
Fadel, F. M. A., Fayyaz, S., Japtok, L., & Kleuser, B. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453213 · Cited by 34
Sphingosine kinase 2 promotes lipotoxicity in pancreatic β‐cells and the progression of diabetes
Song, Z., Wang, W., Li, N., Yan, S., Rong, K., Lan, T., & Xia, P. (2018) · The FASEB Journal · doi:10.1096/fj.201801496r · Cited by 33
CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance
Petersen, M. C., & Jurczak, M. J. (2016) · The Journal of Physiology · doi:10.1113/jp271677 · Cited by 32
Sauvé, M., Hui, S., Dinh, D. D., Foltz, W. D., Momen, A., Nedospasov, S. A., Offermanns, S., Husain, M., Kroetsch, J. T., Lidington, D., et al. (2016) · Diabetes · doi:10.2337/db15-1450 · Cited by 30
Anderson, A. K., Lambert, J. M., Montefusco, D. J., Tran, B. N., Roddy, P. L., Holland, W. L., & Cowart, L. A. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000875 · Cited by 30
Self-citationSphingolipids in the Heart: From Cradle to Grave
Kovilakath, A., Jamil, M., & Cowart, L. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00652 · Cited by 28
Self-citationLiu, M., Frej, C., Langefeld, C. D., Divers, J., Bowden, D. W., Carr, J. J., Gebre, A. K., Xu, J., Larsson, B., Dahlbäck, B., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.p089409 · Cited by 27
Human adiponectin receptor AdipoR1 assumes closed and open structures
Tanabe, H., Fujii, Y., Okada‐Iwabu, M., Iwabu, M., Kano, K., Kawana, H., Hato, M., Nakamura, Y., Terada, T., Kimura‐Someya, T., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01160-4 · Cited by 27
Peterson, L. R., Jiang, X., Chen, L., Goldberg, A. C., Farmer, M. S., Ory, D. S., & Schaffer, J. E. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000669 · Cited by 20
An adiponectin-S1P autocrine axis protects skeletal muscle cells from palmitate-induced cell death
Botta, A. M., Elizbaryan, K., Tashakorinia, P., Lam, N. H., & Sweeney, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01332-5 · Cited by 18
Sydor, S., Sowa, J., Megger, D. A., Schlattjan, M., Jafoui, S., Wingerter, L., Carpinteiro, A., Baba, H. A., Bechmann, L. P., Sitek, B., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.03.002 · Cited by 15
Bergougnan, L., Andersen, G., Plum‐Mörschel, L., Evaristi, M. F., Poirier, B., Tardat, A., Ermer, M., Herbrand, T., Arrubla, J., Coester, H. V., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14632 · Cited by 15
Ganbaatar, B., Fukuda, D., Shinohara, M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Hirata, K., & Sata, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.54916 · Cited by 14
Weyler, J., Verrijken, A., Hornemann, T., Vonghia, L., Dirinck, E. L., von Eckardstein, A., Vanwolleghem, T., Michielsen, P. P., PEIFFER, F. W., Driessen, A. L. C., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01612-7 · Cited by 10
Cited by
Wang, X., Li, H., Sheng, Y., He, B., Liu, Z., Li, W., Yu, S., Wang, J., Zhang, Y., Chen, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116071 · Cited by 29
Fiorenza, M., Checa, A., Sandsdal, R. M., Jensen, S. B. K., Juhl, C. R., Noer, M. H., Bogh, N. P., Lundgren, J. R., Janus, C., Stallknecht, B. M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101629 · Cited by 14
Metadata
- Authors
- Green, C. D., Maceyka, M., Cowart, L. A., & Spiegel, S.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 33
- Issue
- 7
- Pages
- 1293-1306
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3181180049
- Cited by
- 327
- References
- 124
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.